Patents by Inventor Marcin M. Kaminski

Marcin M. Kaminski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS OF ADP-DEPENDENT GLUCOKINASE (ADPGK) AND GLYCEROL-3-PHOSPHATE DEHYDROGENASE (GPD2) FOR THERAPY
    Publication number: 20160113958
    Abstract: Described are compounds capable of modulating (a) the biological activity of ADP-dependent glucokinase (ADPGK) and/or glycerol-3-phosphate dehydrogenase (GPD2) or (b) the expression of the gene encoding ADPGK or GPD2 for use in treating a disease (a) associated with aberrant cell proliferation, e.g., a neoplasm, or (b) of the immune system, e.g., an autoimmune disease.
    Type: Application
    Filed: December 3, 2015
    Publication date: April 28, 2016
    Inventors: Peter Krammer, Marcin M. Kaminski, Karsten Gulow, Sven W. Sauer
  • MODULATORS OF ADP-DEPENDENT GLUCOKINASE (ADPGK) AND GLYCEROL-3-PHOSPHATE DEHYDROGENASE (GPD2) FOR THERAPY
    Publication number: 20140171624
    Abstract: Described are compounds capable of modulating (a) the biological activity of ADP-dependent glucokinase (ADPGK) and/or glycerol-3-phosphate dehydrogenase (GPD2) or (b) the expression of the gene encoding ADPGK or GPD2 for use in treating a disease (a) associated with aberrant cell proliferation, e.g., a neoplasm, or (b) of the immune system, e.g., an autoimmune disease.
    Type: Application
    Filed: December 6, 2013
    Publication date: June 19, 2014
    Applicant: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTES
    Inventors: Peter Krammer, Marcin M. Kaminski, Karsten Gulow, Sven W. Sauer
  • FLUOROQUINOLONES FOR THE TREATMENT AND/OR PROPHYLAXIS OF INFLAMMATORY DISEASES
    Publication number: 20130079353
    Abstract: The present invention relates to a pharmaceutical composition comprising at least one compound of formula (I) wherein R1 denotes e.g. hydrogen or straight chain C1-C6-alkyl, R2 and R3 denote e.g. hydrogen or straight chain C1-C6-alkyl, or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient for use as a medicament for the treatment of inflammatory diseases or conditions, in particular T-cell mediated inflammatory diseases or conditions.
    Type: Application
    Filed: December 20, 2010
    Publication date: March 28, 2013
    Inventors: Karsten Gülow, Marcin M. Kaminski, H. Peter Krammer